Depression Drugs Market Report by Drug Class (Atypical Antipsychotics, Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs), Selective Serotonin Reuptake Inhibitors (SSRIs), Central Nervous System (CNS) Stimulants, Tricyclic Antidepressants, Monoamine Oxidase Inhibitors, and Others), Disorder Type (Major Depressive Disorder, Obsessive-Compulsive Disorder, Generalized Anxiety Disorder, Panic Disorder, and Others), Drug Type (Generic Drugs, Branded Drugs), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), and Region 2025-2033

Depression Drugs Market Report by Drug Class (Atypical Antipsychotics, Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs), Selective Serotonin Reuptake Inhibitors (SSRIs), Central Nervous System (CNS) Stimulants, Tricyclic Antidepressants, Monoamine Oxidase Inhibitors, and Others), Disorder Type (Major Depressive Disorder, Obsessive-Compulsive Disorder, Generalized Anxiety Disorder, Panic Disorder, and Others), Drug Type (Generic Drugs, Branded Drugs), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), and Region 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A1563

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Depression Drugs Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Breakup by Drug Class
    5.5    Market Breakup by Disorder Type
    5.6    Market Breakup by Drug Type
    5.7    Market Breakup by Distribution Channel
    5.8    Market Breakup by Region
    5.9    Market Forecast
6   Market Breakup by Drug Class
    6.1    Atypical Antipsychotics 
        6.1.1    Market Trends
        6.1.2    Market Forecast
    6.2    Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)
        6.2.1    Market Trends
        6.2.2    Market Forecast
    6.3    Selective Serotonin Reuptake Inhibitors (SSRIs)
        6.3.1    Market Trends
        6.3.2    Market Forecast
    6.4    Central Nervous System (CNS) Stimulants
        6.4.1    Market Trends
        6.4.2    Market Forecast
    6.5    Tricyclic Antidepressants
        6.5.1    Market Trends
        6.5.2    Market Forecast
    6.6    Monoamine Oxidase Inhibitors
        6.6.1    Market Trends
        6.6.2    Market Forecast
    6.7    Others
        6.7.1    Market Trends
        6.7.2    Market Forecast
7   Market Breakup by Disorder Type
    7.1    Major Depressive Disorder
        7.1.1    Market Trends
        7.1.2    Market Forecast
    7.2    Obsessive-Compulsive Disorder
        7.2.1    Market Trends
        7.2.2    Market Forecast
    7.3    Generalized Anxiety Disorder
        7.3.1    Market Trends
        7.3.2    Market Forecast
    7.4    Panic Disorder 
        7.4.1    Market Trends
        7.4.2    Market Forecast
    7.5    Others 
        7.5.1    Market Trends
        7.5.2    Market Forecast
8   Market Breakup by Drug Type
    8.1    Generic Drugs
        8.1.1    Market Trends
        8.1.2    Market Forecast
    8.2    Branded Drugs
        8.2.1    Market Trends
        8.2.2    Market Forecast
9   Market Breakup by Distribution Channel
    9.1    Hospital Pharmacies
        9.1.1    Market Trends
        9.1.2    Market Forecast
    9.2    Retail Pharmacies
        9.2.1    Market Trends
        9.2.2    Market Forecast
    9.3    Online Pharmacies
        9.3.1    Market Trends
        9.3.2    Market Forecast
    9.4    Others
        9.4.1    Market Trends
        9.4.2    Market Forecast
10  Market Breakup by Region
    10.1    North America
        10.1.1    Market Trends
        10.1.2    Market Forecast
    10.2    Europe
        10.2.1    Market Trends
        10.2.2    Market Forecast
    10.3    Asia Pacific
        10.3.1    Market Trends
        10.3.2    Market Forecast
    10.4    Middle East and Africa
        10.4.1    Market Trends
        10.4.2    Market Forecast
    10.5    Latin America
        10.5.1    Market Trends
        10.5.2    Market Forecast
11  SWOT Analysis
    11.1    Overview
    11.2    Strengths
    11.3    Weaknesses
    11.4    Opportunities
    11.5    Threats
12  Value Chain Analysis
13  Porter’s Five Forces Analysis

    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14  Price Analysis
15  Competitive Landscape

    15.1    Market Structure
    15.2    Key Players
    15.3    Profiles of Key Players
        15.3.1    Otsuka Pharmaceutical
        15.3.2    Pfizer
        15.3.3    Eli Lilly and Company
        15.3.4    AstraZeneca
        15.3.5    Novartis
        15.3.6    Bristol-Myers Squibb
        15.3.7    GlaxoSmithKline
        15.3.8    Takeda Pharmaceutical Company
        15.3.9    Allergan
        15.3.10   Johnson & Johnson
        15.3.11   Zhejiang NHU Company Ltd
        15.3.12   Sebela Pharmaceuticals

List of Figures

​Figure 1: Global: Depression Drugs Market: Major Drivers and Challenges
Figure 2: Global: Depression Drugs Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Depression Drugs Market: Breakup by Drug Class (in %), 2024
Figure 4: Global: Depression Drugs Market: Breakup by Disorder Type (in %), 2024
Figure 5: Global: Depression Drugs Market: Breakup by Drug Type (in %), 2024
Figure 6: Global: Depression Drugs Market: Breakup by Distribution Channel (in %), 2024
Figure 7: Global: Depression Drugs Market: Breakup by Region (in %), 2024
Figure 8: Global: Depression Drugs Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 9: Global: Depression Drugs Industry: SWOT Analysis
Figure 10: Global: Depression Drugs Industry: Value Chain Analysis
Figure 11: Global: Depression Drugs Industry: Porter’s Five Forces Analysis
Figure 12: Global: Depression Drugs (Atypical Antipsychotics) Market: Sales Value (in Million USD), 2019 & 2024
Figure 13: Global: Depression Drugs (Atypical Antipsychotics) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 14: Global: Depression Drugs (Serotonin-Norepinephrine Reuptake Inhibitors) Market: Sales Value (in Million USD), 2019 & 2024
Figure 15: Global: Depression Drugs (Serotonin-Norepinephrine Reuptake Inhibitors) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 16: Global: Depression Drugs (Selective Serotonin Reuptake Inhibitors) Market: Sales Value (in Million USD), 2019 & 2024
Figure 17: Global: Depression Drugs (Selective Serotonin Reuptake Inhibitors) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 18: Global: Depression Drugs (Central Nervous System (CNS) Stimulants) Market: Sales Value (in Million USD), 2019 & 2024
Figure 19: Global: Depression Drugs (Central Nervous System (CNS) Stimulants) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 20: Global: Depression Drugs (Tricyclic Antidepressants) Market: Sales Value (in Million USD), 2019 & 2024
Figure 21: Global: Depression Drugs (Tricyclic Antidepressants) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 22: Global: Depression Drugs (Monoamine Oxidase Inhibitors) Market: Sales Value (in Million USD), 2019 & 2024
Figure 23: Global: Depression Drugs (Monoamine Oxidase Inhibitors) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 24: Global: Depression Drugs (Other Drug Classes) Market: Sales Value (in Million USD), 2019 & 2024
Figure 25: Global: Depression Drugs (Other Drug Classes) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 26: Global: Depression Drugs (Major Depressive Disorder) Market: Sales Value (in Million USD), 2019 & 2024
Figure 27: Global: Depression Drugs (Major Depressive Disorder) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 28: Global: Depression Drugs (Obsessive-Compulsive Disorder) Market: Sales Value (in Million USD), 2019 & 2024
Figure 29: Global: Depression Drugs (Obsessive-Compulsive Disorder) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 30: Global: Depression Drugs (Generalized Anxiety Disorder) Market: Sales Value (in Million USD), 2019 & 2024
Figure 31: Global: Depression Drugs (Generalized Anxiety Disorder) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 32: Global: Depression Drugs (Panic Disorder) Market: Sales Value (in Million USD), 2019 & 2024
Figure 33: Global: Depression Drugs (Panic Disorder) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 34: Global: Depression Drugs (Other Disorder Types) Market: Sales Value (in Million USD), 2019 & 2024
Figure 35: Global: Depression Drugs (Other Disorder Types) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 36: Global: Depression Drugs (Generic Drugs) Market: Sales Value (in Million USD), 2019 & 2024
Figure 37: Global: Depression Drugs (Generic Drugs) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 38: Global: Depression Drugs (Branded Drugs) Market: Sales Value (in Million USD), 2019 & 2024
Figure 39: Global: Depression Drugs (Branded Drugs) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 40: Global: Depression Drugs Market: Sales through Hospital Pharmacies (in Million USD), 2019 & 2024
Figure 41: Global: Depression Drugs Market Forecast: Sales through Hospital Pharmacies (in Million USD), 2025-2033
Figure 42: Global: Depression Drugs Market: Sales through Retail Pharmacies (in Million USD), 2019 & 2024
Figure 43: Global: Depression Drugs Market Forecast: Sales through Retail Pharmacies (in Million USD), 2025-2033
Figure 44: Global: Depression Drugs Market: Sales through Online Pharmacies (in Million USD), 2019 & 2024
Figure 45: Global: Depression Drugs Market Forecast: Sales through Online Pharmacies (in Million USD), 2025-2033
Figure 46: Global: Depression Drugs Market: Sales through Other Distribution Channels (in Million USD), 2019 & 2024
Figure 47: Global: Depression Drugs Market Forecast: Sales through Other Distribution Channels (in Million USD), 2025-2033
Figure 48: North America: Depression Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 49: North America: Depression Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 50: Europe: Depression Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 51: Europe: Depression Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 52: Asia Pacific: Depression Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 53: Asia Pacific: Depression Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 54: Middle East and Africa: Depression Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 55: Middle East and Africa: Depression Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 56: Latin America: Depression Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 57: Latin America: Depression Drugs Market Forecast: Sales Value (in Million USD), 2025-2033

List of Tables

Table 1: Global: Depression Drugs Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Depression Drugs Market Forecast: Breakup by Drug Class (in Million USD), 2025-2033
Table 3: Global: Depression Drugs Market Forecast: Breakup by Disorder Type (in Million USD), 2025-2033
Table 4: Global: Depression Drugs Market Forecast: Breakup by Drug Type (in Million USD), 2025-2033
Table 5: Global: Depression Drugs Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
Table 6: Global: Depression Drugs Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 7: Global: Depression Drugs Market Structure
Table 8: Global: Depression Drugs Market: Key Players

Depression Drugs Market Report by Drug Class (Atypical Antipsychotics, Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs), Selective Serotonin Reuptake Inhibitors (SSRIs), Central Nervous System (CNS) Stimulants, Tricyclic Antidepressants, Monoamine Oxidase Inhibitors, and Others), Disorder Type (Major Depressive Disorder, Obsessive-Compulsive Disorder, Generalized Anxiety Disorder, Panic Disorder, and Others), Drug Type (Generic Drugs, Branded Drugs), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), and Region 2025-2033
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials